TC BioPharm (Holdings) plc - American Depositary Shares (TCBP)
0.5000
-1.0400 (-67.53%)
TC BioPharm (Holdings) plc is a biotechnology company focused on developing innovative cell therapies for the treatment of cancer and other serious diseases
The company specializes in harnessing the power of the immune system, specifically employing techniques involving gamma delta T-cells, to create advanced therapeutics aimed at enhancing patient outcomes. Through rigorous research and clinical trials, TC BioPharm is dedicated to bringing transformative treatments to patients suffering from a variety of conditions, ultimately striving to improve healthcare and expand therapeutic options in the field of oncology and beyond.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
TC BioPharm's Phase 2B trial of TCB008 in AML progresses as the first Cohort B patient completes dosing. Enrollment continues, with data expected in 2025.
